Retinal determination network reactivation drives chemoresistance and blocks myeloid differentiation in acute myeloid leukemia
{{output}}
Acute myeloid leukemia (AML) is a heterogeneous malignancy driven by abnormal transcriptional programs that block myeloid differentiation and sustain self-renewal. Despite treatment advances over the last 30 years, refractory responses remain common, underscor... ...
